<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15550207</article-id>
      <article-id pub-id-type="pmc">3328987</article-id>
      <article-id pub-id-type="publisher-id">04-0127</article-id>
      <article-id pub-id-type="doi">10.3201/eid1011.040127</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dispatch</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Dispatch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Burkholderia cenocepacia</italic> Vaginal Infection in Patient with Smoldering Myeloma and Chronic Hepatitis C</article-title>
        <alt-title alt-title-type="running-head"><italic>Burkholderia cenocepacia</italic> Vaginal Infection</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Petrucca</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cipriani</surname>
            <given-names>Paola</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sessa</surname>
            <given-names>Rosa</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teggi</surname>
            <given-names>Antonella</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pustorino</surname>
            <given-names>Rosalia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santapaola</surname>
            <given-names>Daniela</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Nicoletti</surname>
            <given-names>Mauro</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">&#x2021;</xref>
        </contrib>
        <aff id="aff1"><label>*</label>II Facolt&#xE0; di Medicina e Chirurgia dell'Universit&#xE0; "La Sapienza," Rome, Italy;</aff>
        <aff id="aff2"><label>&#x2020;</label>I Facolt&#xE0; di Medicina e Chirurgia dell'Universit&#xE0; "La Sapienza," Rome, Italy;</aff>
        <aff id="aff3"><label>&#x2021;</label>Universit&#xE0; "G. D'Annunzio," Chieti, Italy</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Mauro Nicoletti, Dipartimento di Scienze Biomediche, Sezione di Microbiologia&#x2013;Universit&#xE0; &#x201C;G. D&#x2019;Annunzio,&#x201D; Via dei Vestini 31, 66100, Chieti, Italy; fax: +39-06-49914626; email: <email xlink:href="mauro.nicoletti@uniroma1.it">mauro.nicoletti@uniroma1.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2004</year>
      </pub-date>
      <volume>10</volume>
      <issue>11</issue>
      <fpage>1957</fpage>
      <lpage>1959</lpage>
      <abstract>
        <p>We report a case of a vaginal infection caused by a strain of <italic>Burkholderia cenocepacia</italic>. The strain was isolated from vaginal swab specimens from a 68-year-old woman with smoldering myeloma and chronic hepatitis C virus infection who was hospitalized for abdominal abscess. Treatment with piperacillin/tazobactam eliminated <italic>B. cenocepacia</italic> infection and vaginal symptoms.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Burkholderia cenocepacia</kwd>
        <kwd>smoldering myeloma</kwd>
        <kwd>SMM</kwd>
        <kwd>hepatitis C virus</kwd>
        <kwd>HCV</kwd>
        <kwd>dispatch</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Members of genus <italic>Burkholderia</italic> are aerobic, non&#x2013;spore-forming, catalase-positive, gram-negative bacteria; most are oxidase positive (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). This genus comprises opportunistic pathogens responsible for important infections in immunocompromised persons and in cystic fibrosis (CF) patients (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). To date, the genus <italic>Burkholderia</italic> comprises more than 30 species, including the <italic>Burkholderia cepacia</italic> complex, <italic>B. mallei</italic>, and <italic>B. pseudomallei</italic> (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). The <italic>B. cepacia</italic> complex is a group of microorganisms composed of at least nine closely related genomovars (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). All genomovars have been shown to cause infections, and <italic>B. cenocepacia</italic> and <italic>B. multivorans</italic> (genomovars III and II, respectively) are the genomovars most frequently isolated from CF patients (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>&#x2013;</italic><xref ref-type="bibr" rid="R7"><italic>7</italic></xref>).</p>
    <p>Nosocomial infections caused by <italic>B. cepacia</italic> complex have been reported in non-CF patients, principally associated with the use of contaminated disinfectants, anaesthetic solutions, and invasive treatments such as urinary and intravenous catheterization (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). These strains are intrinsically resistant to most antimicrobial agents and are difficult to eliminate (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). Cases of <italic>B. cepacia</italic> complex infections are underestimated because of the complex taxonomy of this genus and the poor sensitivity and specificity of commercial identification systems (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>). Recently, molecular methods, mainly polymerase chain reaction (PCR)-based, have been developed to circumvent this issue (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref><italic>&#x2013;</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>).</p>
    <p>We report a case of vaginal infection, caused by <italic>B. cenocepacia</italic>, in a patient affected by smoldering myeloma, and chronic hepatitis C virus (HCV) infection. Bacterial identification at species level was assessed by four combined PCR&#x2013;based molecular methods. Therapy based on treatment with piperacillin/tazobactam completely eliminated the infection as well as the vaginal symptoms.</p>
    <sec>
      <title>Case Report</title>
      <p>In August 2003, a 68-year-old woman with smoldering myeloma and chronic HCV infection (the patient had cirrhosis since 1994) was admitted to the "Sant'Andrea" Hospital (2nd Faculty of Medicine, "La Sapienza" University, Rome, Italy), with a 15-day history of fever, malaise, asthenia, fatigue, abdominal pain, and swelling of from lower limbs. One week before admission, she had been treated with ciprofloxacin (500 mg twice a day) without improvement of any of the clinical symptoms. On admission (day 1), the patient had a fever (38.4&#xB0;C) and showed abundant ascitic fluid and jaundice. Laboratory values were indicative of macrocytic anemia (erythrocytes, 3.6 x 10<sup>9</sup>/L; hemoglobin, 110 g/L; mean corpuscular volume, 103 fL; hematocrit, 31%; serum iron level, 10.74 &#xB5;mol/L; and serum ferritin level, 170 &#xB5;g/L. Platelet count was 46 x 10<sup>9</sup>/L, and leukocyte count was 14 x 10<sup>9</sup>/L with neutrophils (13 x 10<sup>9</sup>/L) and lymphocytes (0.5 x 10<sup>9</sup>/L). The patient had high values of the erythrocyte sedimentation rate (ESR) in the first hour (71 mm/h) and C-reactive protein (CRP) (4.1 mg/L). Increased total serum proteins (8.1 g/dL) and hypoalbuminemia (23 g/L) were also detected. Six blood samples were taken at 3-hour intervals during the first day of hospitalization and cultured to detect the growth of aerobic and anaerobic microorganisms (Bactec System, Becton Dickinson, Sparks, MD). All blood cultures were negative. Abdominal ecographic and tomographic scans showed a pseudocystic formation in the pancreas. The pancreatic formation was drained because surgical intervention was not appropriate for the patient. On admission day 2, the patient was transferred to the Infectious Diseases Unit; there, intensive strong diuretic therapy was initiated, and a urinary catheter was inserted. Results of microbiologic analysis of urine and of a liquid taken from the pseudocystic formation were negative for common pathogenic bacteria. In spite of these results, the patient was given intravenous amoxicillin/clavulananate (1.2 g three times a day) and amikacin (1 g once a day) (day 3). After 5 days of antimicrobial drug therapy, the clinical symptoms of the patient slightly improved. On day 9 (i.e., after 6 days of antimicrobial drug therapy and 7 days of urinary catheterization), the patient exhibited an abundant white vaginal discharge with vulvar pain and burning. Vaginal swabs were streaked on different selective media. Columbia agar base, supplemented with 5% (vol/vol) sheep blood, and MacConkey agar plates showed a monomicrobic culture constituted by catalase-positive and oxidase-positive gram-negative rods that did not grow under anaerobic conditions. A presumptive identification of <italic>B. cepacia</italic> was made by using the API20NE (bioM&#xE9;rieux, Marcy l'Etoile, France), while the Vitek 2.0 identification system (bioM&#xE9;rieux) did not recognize the isolate as <italic>B. cepacia</italic> (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>). Identification at the species level was achieved by four different PCR-based combined molecular methods, namely, <italic>Dde</italic>I and <italic>Hae</italic>III restriction fragment length polymorphisms (RFLP) of 16S rDNA and <italic>recA</italic> gene analysis, <italic>recA</italic> genomovar-specific PCR, and <italic>recA</italic> sequence analysis (<xref ref-type="bibr" rid="R11"><italic>11</italic></xref><italic>&#x2013;</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). Control strains belonging to different genomovars of <italic>B. cepacia</italic> complex were included in all molecular analyses (<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). Bacterial genomic DNA was extracted by using a commercial kit (Qiagen genomic-tip, Qiagen Inc., Hilden, Germany) as previously described (<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). The bacterial isolate showed a 16S rRNA <italic>Dde</italic>I-RFLP pattern 1 and a <italic>recA Hae</italic>III-RFLP pattern H (data not shown; 14), patterns indicative of <italic>B. cenocepacia</italic> (<xref ref-type="bibr" rid="R11"><italic>11</italic></xref><italic>&#x2013;</italic><xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). Genomovar-specific PCR was performed with primer pairs annealing to internal regions of the <italic>recA</italic> gene (<xref ref-type="bibr" rid="R12"><italic>12</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). A DNA fragment with a molecular mass of approximately 800 bp, consistent with the expected 781-bp <italic>B. cenocepacia</italic> amplification fragment, was successfully amplified with the primer pair BCRG3B1/BCRG3B2 (data not shown) (<xref ref-type="bibr" rid="R12"><italic>12</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). To unambiguously identify the bacterial isolate, we sequenced the amplified <italic>recA</italic> DNA fragment that was subjected to <italic>recA Hae</italic>III-RFLP analysis (<xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). The <italic>recA</italic> DNA sequence of the bacterial isolate (GenBank accession no. AJ786367), subjected to BLAST analysis (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST">http://www.ncbi.nlm.nih.gov/BLAST</ext-link>), showed &gt;99% homology with the <italic>recA</italic> sequence of the <italic>B. cenocepacia</italic> reference strain LMG 18829 (GenBank accession no. AF143784). Phylogenetic analysis, based on <italic>recA</italic> DNA sequences, indicated that the clinical isolate belonged to the <italic>B. cenocepacia</italic> (genomovar III, lineage IIIB) (<xref ref-type="fig" rid="F1">Figure</xref>) (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>).</p>
      <fig id="F1" fig-type="figure" position="float">
        <label>Figure</label>
        <caption>
          <p>The consensus phylogenetic tree of <italic>recA</italic> DNA sequences of <italic>Burkholderia cepacia</italic> complex strains, representative of each genomovar, and of the <italic>B. cenocepacia</italic> isolate (GenBank accession no. AJ786367) was constructed with the PHYLIP package (version 3.6) (<ext-link ext-link-type="uri" xlink:href="http://evolution.genetics.washington.edu/phylip.html">http://evolution.genetics.washington.edu/phylip.html</ext-link>). Only <italic>recA</italic> DNA sequences of reference <italic>B. cenocepacia</italic> strains (genomovar III, lineage IIIB) are included in the tree (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). Alignments were performed with the Clustal W program. Genetic distance is indicated on the scale, and bootstrap analysis for nodes values &gt;70% are shown. GenBank accession numbers of the <italic>recA</italic> DNA sequences are shown for each reference strains.</p>
        </caption>
        <graphic xlink:href="04-0127-F"/>
      </fig>
      <p>The <italic>B. cenocepacia</italic> isolate was resistant to penicillin, mezlocillin, piperacillin, amoxicillin/clavulanate, nitrofurantoin, ciprofloxacin, carbapenems, cephalosporins, aminoglycosides, and tetracycline and sensitive to trimethoprim/sulfamethoxazole and piperacillin/tazobactam. When the antimicrobial drug susceptibility profile was considered, the amoxicillin/clavulanate and amikacin antibiotic therapy was interrupted, and intravenous piperacillin/tazobactam combination was administered (4.5 g, three times a day for 4 weeks). Vaginal swabs were taken every 3 days during the 4 weeks of the antimicrobial drug therapy and, afterwards, every 20 days for a total follow-up period of 3 months. After 10 days of the piperacillin/tazobactam treatment, vaginal symptoms disappeared and cultured vaginal swabs did not show <italic>B. cenocepacia</italic>. After the piperacillin/tazobactam treatment ended, the patient did not exhibit any signs of vaginal infection.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>We think this is the first description of a vaginal infection caused by <italic>B. cenocepacia</italic>. The patient's immunodepression from smoldering myeloma and chronic HCV likely favored vaginal colonization by <italic>B. cenocepacia</italic>. Urinary catheterization might have favored vaginal colonization by <italic>B. cenocepacia</italic>, even if we did not isolate <italic>B. cenocepacia</italic> from catheters, disinfectants, and selected hospital environmental samples analyzed from October 2003 to February 2004 (<xref ref-type="bibr" rid="R15"><italic>15</italic></xref>). Moreover, the antimicrobial agents, ciprofloxacin, and amoxicillin/clavulanate and amikacin, administered to the patient before and during hospitalization, might also have altered the patient's vaginal flora. Piperacillin/tazobactam eliminated vaginal symptoms and <italic>B. cenocepacia</italic> from the vaginal mucosa, thus indicating that the detected isolate was indeed responsible for the infection.</p>
      <p>Microorganisms belonging to the <italic>B. cepacia</italic> complex are difficult to identify by conventional biochemical tests and commercial systems (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). This case report highlights the importance of the use of molecular techniques to quickly and accurately identify members of the <italic>B. cepacia</italic> complex (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). The ability of <italic>B. cenocepacia</italic> to cause vaginal infections is unusual. Further studies are needed to clarify whether specific virulence factors are carried and expressed by the <italic>B. cenocepacia</italic> clinical isolate, conferring to this strain the specific ability to colonize and multiply within the vaginal mucosa.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Petrucca A, Cipriani P, Sessa R, Teggi A, Pustorino R, Santapaola D, et al. <italic>Burkholderia cenocepacia</italic> vaginal infection in patient with smoldering myeloma and chronic hepatitis C. Emerg Infect Dis [serial on the Internet]. 2004 Nov [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1011.040127">http://dx.doi.org/10.3201/eid1011.040127</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Styliani Papadopoulou and Cristina Petrucci for their excellent technical assistance.</p>
      <p>This work was supported by faculty 60% funds granted to R.S. and to M.N., and in part by MURST PRIN research project "Effettori di virulenza in patogeni enterici: caratteristiche e studio delle loro interazioni," granted to M.N.</p>
    </ack>
    <bio>
      <p>Mr. Petrucca is a medical biotechnology student who is doing research at the "Sant'Andrea" Hospital, 2nd Faculty of Medicine, "La Sapienza" University, Rome, Italy. His main research interests include developing new tools to identify bacterial pathogens and regulate gene expression of type III secretion systems in enteroinvasive bacteria.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="book"><string-name><surname>Gillan</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Whittier</surname>
<given-names>S</given-names></string-name>
<italic>Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas</italic> and <italic>Acidovorax</italic> In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolker RH, editors. Manual of clinical microbiology. Washington: American Society of Microbiolgy; <year>1999</year> p. 526&#x2013;38.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>
<article-title>Diversity and significance of <italic>Burkholderia</italic> species occupying diverse ecological niches.</article-title>
<source>Environ Microbiol</source>. <year>2003</year>;<volume>5</volume>:<fpage>719</fpage>&#x2013;<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1046/j.1462-2920.2003.00471.x</pub-id><pub-id pub-id-type="pmid">12919407</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>
<article-title>LiPuma JJ. Molecular epidemiology of <italic>Burkholderia</italic> species.</article-title>
<source>Front Biosci</source>. <year>2003</year>;<volume>8</volume>:<fpage>e55</fpage>&#x2013;<lpage>67</lpage>
<pub-id pub-id-type="doi">10.2741/937</pub-id><pub-id pub-id-type="pmid">12456343</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Holmes</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Goris</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>
<article-title>LiPuma JJ, Govan JRW. <italic>Burkholderia cenocepacia</italic> sp. nov.&#x2014;a new twist to an old story.</article-title>
<source>Res Microbiol</source>. <year>2003</year>;<volume>154</volume>:<fpage>91</fpage>&#x2013;<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/S0923-2508(03)00026-3</pub-id><pub-id pub-id-type="pmid">12648723</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Speert</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Henry</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Corey</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>
<article-title>Epidemiology of <italic>Burkholderia cepacia</italic> complex in patients with cystic fibrosis, Canada.</article-title>
<source>Emerg Infect Dis</source>. <year>2002</year>;<volume>8</volume>:<fpage>181</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">11897071</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Agodi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bachitta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Giannino</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sciacca</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Stefani</surname>
<given-names>S</given-names></string-name>
<article-title><italic>Burkholderia cepacia</italic> complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.</article-title>
<source>J Clin Microbiol</source>. <year>2001</year>;<volume>39</volume>:<fpage>2891</fpage>&#x2013;<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.39.8.2891-2896.2001</pub-id><pub-id pub-id-type="pmid">11474009</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><collab>LiPuma JJ</collab>
<article-title>Spilker T, Gill GH, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribuition of <italic>Burkholderia cepacia</italic> complex species and transmissibility markers in cystic fibrosis.</article-title>
<source>Am J Respir Crit Care Med</source>. <year>2001</year>;<volume>164</volume>:<fpage>92</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">11435245</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Govan</surname>
<given-names>JRW</given-names></string-name>
<article-title>LiPuma JJ. Taxonomy and identification of the <italic>Burkholderia cepacia</italic> complex.</article-title>
<source>J Clin Microbiol</source>. <year>2001</year>;<volume>39</volume>:<fpage>3427</fpage>&#x2013;<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.39.10.3427-3436.2001</pub-id><pub-id pub-id-type="pmid">11574551</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Nzula</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Govan</surname>
<given-names>JR</given-names></string-name>
<article-title>Influence of taxonomic status on the in vitro antimicrobial susceptibility of the <italic>Burkholderia cepacia</italic> complex.</article-title>
<source>J Antimicrob Chemother</source>. <year>2002</year>;<volume>50</volume>:<fpage>265</fpage>&#x2013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkf137</pub-id><pub-id pub-id-type="pmid">12161410</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Henry</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Speert</surname>
<given-names>DP</given-names></string-name>
<article-title>Phenotypic methods for determining genomovar status of the <italic>Burkholderia cepacia</italic> complex.</article-title>
<source>J Clin Microbiol</source>. <year>2001</year>;<volume>39</volume>:<fpage>1073</fpage>&#x2013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1128/JCM.39.3.1073-1078.2001</pub-id><pub-id pub-id-type="pmid">11230429</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Henry</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nzula</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Vancanneyt</surname>
<given-names>M</given-names></string-name>, LiPuma JJ, et al. <article-title><italic>Burkholderia anthina</italic> sp. nov. and <italic>Burkholderia pyrrocinia</italic>, two additional <italic>Burkholderia cepacia</italic> complex bacteria, may confound results of new molecular diagnostic tools.</article-title>
<source>FEMS Immunol Med Microbiol</source>. <year>2002</year>;<volume>33</volume>:<fpage>143</fpage>&#x2013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-695X.2002.tb00584.x</pub-id><pub-id pub-id-type="pmid">12052570</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vermis</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Coenye</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nelis</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Vandamme</surname>
<given-names>P</given-names></string-name>
<article-title>Evaluation of species-specific <italic>recA</italic>-based PCR tests for genomovar level identification within the <italic>Burkholderia cepacia</italic> complex.</article-title>
<source>J Med Microbiol</source>. <year>2002</year>;<volume>51</volume>:<fpage>937</fpage>&#x2013;<lpage>40</lpage><pub-id pub-id-type="pmid">12448677</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bischof</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Byrne</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Radomski</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Av-Gay</surname>
<given-names>Y</given-names></string-name>, <etal/>
<article-title>DNA-based diagnostic approaches for the identification of <italic>Burkholderia cepacia</italic> complex, <italic>Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia</italic> genomovars I and III.</article-title>
<source>J Clin Microbiol</source>. <year>2000</year>;<volume>38</volume>:<fpage>3165</fpage>&#x2013;<lpage>73</lpage><pub-id pub-id-type="pmid">10970351</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Petrucca</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cipriani</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Valenti</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Santapaola</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cimmino</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Scoarughi</surname>
<given-names>GL</given-names></string-name>, <etal/>
<article-title>Molecular characterization of <italic>Burkholderia cepacia</italic> isolates from cystic fibrosis (CF) patients in an Italian CF center.</article-title>
<source>Res Microbiol</source>. <year>2003</year>;<volume>154</volume>:<fpage>491</fpage>&#x2013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/S0923-2508(03)00145-1</pub-id><pub-id pub-id-type="pmid">14499935</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Siddiqui</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Mullingam</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Mahenthiralingam</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Hebden</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Brewrink</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Qaiyumi</surname>
<given-names>S</given-names></string-name>, <etal/>
<article-title>An episodic outbreak of genetically related <italic>Burkholderia cepacia</italic> among non&#x2013;cystic fibrosis patients at a university hospital.</article-title>
<source>Infect Control Hosp Epidemiol</source>. <year>2001</year>;<volume>22</volume>:<fpage>419</fpage>&#x2013;<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1086/501927</pub-id><pub-id pub-id-type="pmid">11583209</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
